DailyStocks Stock Article Search

https://www.fool.com/investing/2024/03/28/eli-lilly-vs-berkshire-hathaway-which-stock-will-b/?source=iedfolrf0000001 Mar 28, 2024 - Don't assume that because Berkshire is worth nearly $900 billion, it's sure to get to $1 trillion first. 0

https://www.fool.com/investing/2024/03/31/have-1500-2-top-growth-stocks-to-buy-right-now/?source=iedfolrf0000001 Mar 31, 2024 - Great companies in steadily growing industries can deliver enviable returns through the years. 0

https://www.fool.com/investing/2024/04/06/eli-lillys-wegovy-competitor-is-causing-supply-con/?source=iedfolrf0000001 Apr 06, 2024 - Things are going exactly as planned for the biotech giant. 0

https://seekingalpha.com/news/4090463-5-stocks-to-watch-on-wednesday-lly-abt-and-more?source=feed_sector_healthcare Apr 17, 2024 - Eli Lilly (LLY), Abbott Laboratories (ABT), Travelers (TRV), Capri (CPRI) and Tapestry (TPR) are the stocks to watch on Wednesday. 0

https://www.fool.com/investing/2024/04/17/why-eli-lilly-stock-beat-the-market-today-while-re/?source=iedfolrf0000001 Apr 17, 2024 - The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals. 0

https://www.fool.com/investing/2023/12/31/eli-lilly-stock-jumped-59-in-2023-is-it-a-good-sto/?source=iedfolrf0000001 Dec 31, 2023 - Sales of its new weight-management drug could be off the charts next year. 0

https://www.fool.com/investing/2024/01/03/missed-out-eli-lilly-best-pharmaceutical-stock/?source=iedfolrf0000001 Jan 03, 2024 - The past three years were bliss for Eli Lilly shareholders, but those not already on board should look at its rival instead. 0

https://www.fool.com/investing/2024/02/08/heres-why-merck-eli-lilly-and-novo-nordisk-stocks/?source=iedfolrf0000001 Feb 08, 2024 - Investors are still excited about obesity treatments and weight-management drugs. 0

https://www.fool.com/investing/2024/02/10/eli-lilly-just-succeeded-where-others-failed-but-d/?source=iedfolrf0000001 Feb 10, 2024 - Potentially adding billions of dollars in revenue might move the needle for the pharmaceutical giant, but that could take years. 0

https://www.fool.com/investing/2024/02/19/3-magnificent-growth-stocks-to-buy-right-now/?source=iedfolrf0000001 Feb 19, 2024 - These stocks share at least two common denominators: a biopharmaceutical focus and great long-term prospects. 0